Dexcom (DXCM) Work In Process (2010 - 2026)

Dexcom (DXCM) has 13 years of Work In Process data on file, last reported at $136.0 million in Q1 2026.

• Quarterly Work In Process rose 111.51% year-over-year to $136.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $136.0 million (up 111.51% YoY) and the FY2025 annual result came in at $105.0 million, up 273.67% from the prior year.
• Work In Process climbed to $136.0 million in Q1 2026 per DXCM's latest filing, from $105.0 million in the prior quarter.
• Across five years, Work In Process topped out at $136.0 million in Q1 2026 and bottomed at $15.8 million in Q1 2022.
• The 5-year median for Work In Process is $36.4 million (2023), against an average of $51.6 million.
• The widest annual swing landed in 2023, when Work In Process retreated 12.97%; it then surged 273.67% in 2025.
• Tracing DXCM's Work In Process over 5 years: stood at $17.2 million in 2022, then soared by 74.42% to $30.0 million in 2023, then decreased by 6.33% to $28.1 million in 2024, then surged by 273.67% to $105.0 million in 2025, then gained by 29.52% to $136.0 million in 2026.
• Per Business Quant, the three latest DXCM Work In Process figures stand at $136.0 million (Q1 2026), $105.0 million (Q4 2025), and $78.6 million (Q3 2025).

Peer Comparison